Skip to main content
. 2024 Mar 10;13(17):2304626. doi: 10.1002/adhm.202304626

Figure 10.

Figure 10

a) Schematic representation of the preparation of carbon nanovesicles from Brij L76 and encapsulation of bevacizumab and its anti‐angiogenic activity in fundus images. Reproduced with permission.[ 203 ] Copyright 2023, Elsevier. b) Schematic illustration of the preparation and the immunomodulatory function of miRNA‐223‐based MSN nanoplatform for targeted therapy in ROP. Reproduced with permission.[ 204 ] Copyright 2023, Elsevier.